CVKD / Cadrenal Therapeutics, Inc. - Net Long/Short Value

Cadrenal Therapeutics, Inc.

CVKD / Cadrenal Therapeutics, Inc. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
Archer Investment Corp
Raymond James Financial Inc
Tower Research Capital LLC (TRC)
Vanguard Group Inc
IFP Advisors, Inc
Advisor Group Holdings, Inc.
FSKAX - FIDELITY CONCORD STREET TRUST - Fidelity Total Market Index Fund
VTSMX - VANGUARD INDEX FUNDS - Vanguard Total Stock Market Index Fund Investor Shares
IWC - iSHARES TRUST - iShares Micro-Cap ETF
EQ ADVISORS TRUST - 1290 VT Micro Cap Portfolio Class IB
UBS Group AG
VEXMX - VANGUARD INDEX FUNDS - Vanguard Extended Market Index Fund Investor Shares
Jones Financial Companies Lllp
Geode Capital Management, Llc
Wells Fargo & Company/mn
FSMAX - FIDELITY CONCORD STREET TRUST - Fidelity Extended Market Index Fund
BlackRock, Inc.
Harbour Investments, Inc.
FCFMX - FIDELITY CONCORD STREET TRUST - Fidelity Series Total Market Index Fund
Bank Of America Corp /de/
Morgan Stanley
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista